XML 34 R25.htm IDEA: XBRL DOCUMENT v3.24.0.1
Common Stock, Stock Options and Warrants (Details) - USD ($)
 3 Months Ended 12 Months Ended
Oct. 10, 2023
Dec. 31, 2023
Dec. 31, 2022
Sep. 30, 2023
Apr. 29, 2023
Nov. 08, 2022
Oct. 04, 2022
Common Stock, Stock Options and Warrants [Line Items]              
Shares of common stock issued 108,778            
Fair value of common stock issued (in Dollars) $ 76,146            
Common shares reserved   75,745,018          
Options to purchase shares expired            
Contractual term   10 years          
Share price per value (in Dollars per share)             $ 1.25
Estimated price per share (in Dollars per share)   $ 0.97          
Stock-based compensation expense (in Dollars)   $ 3,058,185 $ 1,201,081        
Unrecognized compensation cost (in Dollars)   $ 5,905,736          
Weighted average period term       1 year 9 months      
Weighted average exercise price per share (in Dollars per share)   $ 0.7          
Shares exercisable   9,231,839          
Term of options outstanding   7 years 4 months 28 days          
Employees [Member]              
Common Stock, Stock Options and Warrants [Line Items]              
Options granted to purchase shares 3,725,000           3,375,000
Directors [Member]              
Common Stock, Stock Options and Warrants [Line Items]              
Options granted to purchase shares 300,000           375,000
Consultants [Member]              
Common Stock, Stock Options and Warrants [Line Items]              
Options granted to purchase shares 60,000         50,000 50,000
Share price per value (in Dollars per share)           $ 1.04  
Board of Directors [Member]              
Common Stock, Stock Options and Warrants [Line Items]              
Share price per value (in Dollars per share) $ 0.7            
Warrants [Member]              
Common Stock, Stock Options and Warrants [Line Items]              
Weighted average period   2 years 6 months          
2014 Stock Incentive Plan [Member]              
Common Stock, Stock Options and Warrants [Line Items]              
Common shares reserved   866,667          
Shares outstanding   795,171          
Warrants to purchase common shares   4,829          
Options to purchase shares expired   66,667          
2018 Omnibus Stock Incentive Plan [Member]              
Common Stock, Stock Options and Warrants [Line Items]              
Common shares reserved   2,000,000          
Shares outstanding   1,760,000          
Warrants to purchase common shares   116,667          
Options to purchase shares expired   13,333          
Remaining shares transferred   110,000          
2020 Plan [Member]              
Common Stock, Stock Options and Warrants [Line Items]              
Common shares reserved   3,110,000          
Shares outstanding   1,820,000          
Options to purchase shares expired   50,000          
Remaining shares transferred   1,240,000          
2021 Stock Plan [Member]              
Common Stock, Stock Options and Warrants [Line Items]              
Common shares reserved   8,740,000          
Shares outstanding   8,630,000          
Warrants to purchase common shares   75,000          
Remaining shares transferred   35,000          
Shares available for future grants   7,650,000          
2023 Stock Plan [Member]              
Common Stock, Stock Options and Warrants [Line Items]              
Common shares reserved   12,035,000          
Shares outstanding   4,385,000          
Stock Option [Member]              
Common Stock, Stock Options and Warrants [Line Items]              
Estimated price per share (in Dollars per share)   $ 0.54          
NoveCite Plan [Member]              
Common Stock, Stock Options and Warrants [Line Items]              
Common shares reserved   2,000,000          
Shares available for future grants   88,500          
Options granted to purchase shares   1,911,500          
Stock-based compensation expense (in Dollars)   $ 19,858 $ 33,333        
Unrecognized compensation cost (in Dollars)   $ 27,717          
Options outstanding to purchase shares   1,911,500          
Weighted average exercise price per share (in Dollars per share)   $ 0.24          
Shares exercisable   1,772,917          
Options vest over terms   10 years          
Term of options outstanding   7 years 1 month 20 days          
Weighted average period   6 months          
Citius Oncology Plan [Member]              
Common Stock, Stock Options and Warrants [Line Items]              
Common shares reserved         15,000,000    
Options granted to purchase shares       12,750,000      
Estimated price per share (in Dollars per share)       $ 1.65      
Stock-based compensation expense (in Dollars)   $ 1,917,000          
Unrecognized compensation cost (in Dollars)   $ 16,925,500          
Options outstanding to purchase shares   12,600,000          
Shares exercisable   1,638,889          
Options vest over terms       10 years      
Term of options outstanding   9 years 6 months          
Weighted average period   2 years 4 months 24 days          
Exercise price per share (in Dollars per share)       $ 2.15      
Common shares forfeited       150,000